Surgery For Apnoea
| Procedure name | Uvulopalatopharyngoplasty (UPPP) |
|---|---|
| Primary indication | Moderate to severe obstructive sleep apnoea |
| Typical candidate | Anatomical obstruction in the soft palate/throat |
| Invasiveness | Surgical procedure requiring general anaesthesia |
| Hospital stay | Typically overnight |
| Common side effects | Post-operative pain, throat swelling, temporary voice changes |
| Success rate | Variable, often reported as a reduction in apnoea events, not a cure |
| Alternative first-line treatment | Continuous Positive Airway Pressure (CPAP) therapy |
Origin and history
Surgical interventions for obstructive sleep apnoea (OSA) originated in the United States in the late 20th century, with foundational work emerging in the 1980s. The development was a direct response to the limitations of the then-newly introduced continuous positive airway pressure (CPAP) therapy, which some patients could not tolerate. Early procedures were adaptations of existing otorhinolaryngological surgeries, such as tonsillectomy and uvulopalatopharyngoplasty (UPPP), originally used for chronic throat conditions. The recognition of OSA as a distinct clinical syndrome with multiple potential anatomical obstruction sites drove the evolution of more targeted procedures. Over subsequent decades, surgical approaches expanded to include nasal, palatal, tongue base, and maxillofacial surgeries, reflecting a better understanding of airway collapse. The field continues to evolve with the introduction of less invasive techniques and refined patient selection criteria.
What it is for
Surgery for sleep apnoea is specifically for treating obstructive sleep apnoea (OSA) when first-line treatments are ineffective or unsuitable. Its primary purpose is to anatomically modify the upper airway to prevent its collapse during sleep, thereby reducing or eliminating apnoea events. It is not a primary treatment for central sleep apnoea, which involves a neurological control problem rather than a physical blockage. Surgery aims to address specific, surgically correctable anatomical abnormalities that contribute to airway obstruction, such as enlarged tonsils, a deviated nasal septum, or a recessed jaw. The goal is to improve airway patency to facilitate easier breathing during sleep without the need for a device. It is also considered for patients who suffer from severe daytime sleepiness and related health complications despite attempting conservative management.
Overview
Surgery for obstructive sleep apnoea encompasses a wide range of procedures targeting different levels of the upper airway. These procedures are typically categorized by the anatomical site they address: the nose, the palate and tonsils, the tongue base, or the facial skeleton. Common procedures include septoplasty and turbinate reduction for nasal obstruction, uvulopalatopharyngoplasty (UPPP) for palatal and pharyngeal tissue, genioglossus advancement and hyoid suspension for tongue base collapse, and maxillomandibular advancement (MMA) for skeletal deficiencies. Surgery is not a single universal operation but a tailored approach based on a thorough evaluation of the individual's specific pattern of airway collapse. The evaluation often includes drug-induced sleep endoscopy, which allows surgeons to visualize the site of obstruction while the patient is in a sleep-like state. Success rates vary significantly depending on the procedure, the patient's anatomy, and the severity of their OSA.
What to know
Surgery for sleep apnoea is generally considered a second-line treatment after positive airway pressure therapy or oral appliance therapy has failed or been rejected. A comprehensive preoperative workup is essential, including polysomnography (sleep study) and precise anatomical localization of the obstruction sites. Patients must understand that surgical success is often defined as a significant reduction in the apnoea-hypopnoea index (AHI), not necessarily a complete cure, and many patients may still require some form of adjunctive therapy post-operatively. Recovery times and post-operative discomfort vary dramatically, from relatively minor pain with nasal surgery to a prolonged and potentially difficult recovery with major skeletal procedures like maxillomandibular advancement. There are inherent risks such as bleeding, infection, changes in voice or swallowing, and, in rare cases, a worsening of breathing. Long-term follow-up is necessary as the benefits of some procedures, particularly soft tissue surgeries, may diminish over time.
Common questions
A common question is whether surgery provides a permanent cure for sleep apnoea, to which the answer is that it can be curative for some patients with specific, corrected anatomical issues, but for many it is a management strategy that reduces severity. Patients often ask about the success rate, which is highly procedure-dependent, with maxillomandibular advancement having the highest reported success rates for severe OSA, while isolated UPPP has more variable outcomes. Many inquire if they will still need to use their CPAP machine after surgery, and while some patients can discontinue it, others may need to continue at a lower pressure or use it intermittently. Questions about pain and recovery duration are frequent, with soft palate procedures typically involving one to two weeks of significant throat pain, whereas skeletal surgeries involve weeks of a liquid diet and facial swelling. People also ask if weight loss can replace the need for surgery, and while weight loss is strongly recommended and can improve OSA, it may not resolve obstructions caused by fixed anatomical factors. Finally, patients question how to choose a surgeon, emphasizing the importance of selecting an otolaryngologist or oral and maxillofacial surgeon with specific fellowship training in sleep medicine and sleep surgery.
Pros and cons
A significant pro of successful surgery is the potential for a device-free solution, eliminating the nightly burden and discomfort of CPAP masks or oral appliances. It can provide a definitive anatomical correction, particularly in cases of gross anatomical abnormalities like massive tonsillar hypertrophy or severe retrognathia. For some patients, it leads to a dramatic improvement in sleep quality, daytime alertness, and associated cardiovascular risks. The primary con is the risk of surgical failure, where the procedure does not significantly improve the AHI, leaving the patient with ongoing sleep apnoea and the added experience of an unnecessary operation and recovery. A common mistake is undergoing a single, limited procedure like UPPP for multi-level collapse without adequate staging or planning, leading to poor outcomes and patient regret. Other cons include the potential for permanent side effects like velopharyngeal insufficiency (nasal regurgitation of fluids), changes in taste or voice, and the inherent risks of anaesthesia and major surgery.
Who it suits
Surgery best suits patients with a clearly identified, surgically correctable anatomical abnormality that is the primary cause of their airway obstruction. It is particularly suitable for young, otherwise healthy patients with severe OSA who have failed or are intolerant of CPAP therapy and have specific findings like mandibular deficiency. Patients with significant nasal obstruction due to a deviated septum or enlarged turbinates may benefit greatly from nasal surgery, often as an adjunct to improve CPAP tolerance. Those with isolated palatal collapse or enlarged tonsils may be good candidates for palatal procedures like UPPP or tonsillectomy. Maxillomandibular advancement is typically reserved for patients with severe retrognathia or those who have failed other surgeries, and they must be willing to accept the significant recovery process. It is generally less suited for patients whose primary issue is obesity without a focal anatomical lesion, as weight loss should be the primary intervention, or for those with central sleep apnoea or unstable medical conditions that increase surgical risk.
